MedTech News
Vivani Medical initiates first-in-human GLP-1-eluting implant study
Vivani Medical (Nasdaq:VANI) announced today that it initiated screening and enrollment for a first-in-human trial of its GLP-1 implant.
FDA greenlights expansion of BiVacor artificial heart study
BiVacor announced today that it completed the first phase of an FDA early feasibility study (EFS) for its Total Artificial Heart (TAH).
Single X-ray projection achieves 3D imaging, reducing radiation exposure
Researchers from UC Irvine’s Departments of Radiological Sciences and Biomedical Engineering recently published a study in the journal Science Advances in which they introduce a technology that achieves 3D imaging with a single X-ray projection called X-ray–Induced Acoustic Computed Tomography (XACT).
FDA clears new stemless anatomical total shoulder implant from Smith+Nephew
Smith+Nephew (NYSE: SNN)+
announced that it received FDA clearance for its stemless anatomic total shoulder for the Aetos system.
CardioFocus completes first-in-human pulsed-field ablation case in investigational trial
CardioFocus announced today that investigators completed the first series of treatments in a study of its OptiShot pulsed-field ablation system.
Magnetically driven robotic microscrews offer a new solution for fallopian tube blockages
Infertility affects an estimated 186 million people worldwide, with fallopian tube obstruction contributing to 11–67% of female infertility cases. In AIP Advances researchers at the SIAT Magnetic Soft Microrobots Lab have developed an innovative solution using a magnetically driven robotic microscrew to treat fallopian tube blockages.
Scientists develop scans that light up aggressive cancer tumors for better treatment
Researchers have used a chemical compound to light up treatment-resistant cancers on imaging scans, in a breakthrough that could help medical professionals better target and treat cancer.
Abbott Announces First-in-World Leadless Pacing Procedures in the Left Bundle Branch Area of the Heart
ABBOTT PARK, Ill., Dec. 17, 2024 /PRNewswire/ — Abbott (NYSE: ABT) today announced the successful completion of the world’s first in-human leadless left bundle branch area pacing (LBBAP) procedures using the company’s investigational AVEIR™ Conduction System Pacing (CSP) leadless pacemaker system, as part of a feasibility study.